Many drugs in works to inhibit drug-resistant strains of MRSA

Pharmaceutical research companies in the United States are currently testing 338 new products to fight contagious diseases, including 11 medicines and four vaccines to treat staph infections. A new report released Tuesday by PhRMA said the medicines being developed to eradicate staph are designed to inhibit drug-resistant strains of Staphylococcus aureus. "America's pharmaceutical research companies are working hard to develop new medicines that will treat staph and even prevent patients from infection in the first place," said PhRMA president and CEO Billy Tauzin. Other drugs in development, according to the report, include a hepatitis C treatment and a medicine to stop the life cycle of the bacteria that cause tuberculosis. PhRMA's report is available on the association's Web site, www.phrma.org.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, clickhere.